Acta Reumatologica Portuguesa
Scope & Guideline
Elevating rheumatology through collaboration and innovation.
Introduction
Aims and Scopes
- Multidisciplinary Collaboration in Rheumatology:
The journal emphasizes the importance of collaborative approaches between various specialties, such as Dermatology and Rheumatology, to enhance patient care and treatment outcomes for complex conditions like psoriatic disease. - Clinical and Case Studies:
A significant portion of the journal's content is dedicated to clinical case reports and studies that provide insights into rare and complex rheumatic conditions, helping to broaden the understanding of these diseases. - Treatment and Management Strategies:
The journal regularly publishes research on the efficacy of various treatment modalities, including biologics, non-pharmacological interventions, and the management of comorbidities like osteoporosis and obesity in rheumatic patients. - Patient-Centered Care and Quality of Life:
There is a consistent focus on improving the patient-physician relationship, assessing disease activity, and fostering person-centered care, which are crucial for enhancing the quality of life of patients with rheumatic diseases. - Emerging Trends and Innovations:
The journal also highlights innovative research methodologies and emerging trends in rheumatology, including the exploration of biobanks and the impact of COVID-19 on rheumatology practices.
Trending and Emerging
- Impact of COVID-19 on Rheumatology Practice:
The journal has increasingly focused on the implications of the COVID-19 pandemic for rheumatology, including its effects on treatment regimens and patient outcomes, emphasizing the need for adaptive strategies in clinical practice. - Multidisciplinary Approaches to Patient Care:
There is a growing emphasis on multidisciplinary care models that integrate various healthcare professionals to improve management strategies for complex rheumatic diseases, reflecting a trend towards holistic patient management. - Role of Obesity and Comorbidities in Rheumatic Diseases:
Recent studies have shown a rising interest in the role of obesity and other comorbidities in the progression and management of rheumatic diseases, underscoring the importance of a comprehensive approach to treatment. - Patient-Reported Outcomes and Quality of Life Assessments:
The trend towards incorporating patient-reported outcomes and quality of life assessments into clinical research is gaining momentum, indicating a shift towards prioritizing patient experiences and satisfaction. - Innovations in Treatment Protocols and Biologics:
The journal showcases an increasing number of papers discussing the latest innovations in biologic therapies and treatment protocols, highlighting advancements in personalized medicine and targeted therapies in rheumatology.
Declining or Waning
- Traditional Therapies and Conventional Approaches:
There seems to be a decline in the publication of studies focusing solely on traditional therapies and conventional management approaches, as the field increasingly emphasizes innovative and personalized treatment strategies. - Rare Disease Case Reports:
Although rare diseases are still addressed, the frequency of dedicated case reports on extremely uncommon rheumatic conditions appears to be waning, possibly due to a shift towards more prevalent conditions and broader patient populations. - Basic Science Research:
Research focusing on basic science aspects of rheumatic diseases, such as molecular mechanisms and pathophysiology, is less frequently published, indicating a potential shift towards clinical applications and outcomes. - Epidemiological Studies on Historical Trends:
There is a noticeable reduction in epidemiological studies that analyze historical trends in rheumatic diseases, as recent research focuses more on current challenges and immediate concerns, such as the COVID-19 pandemic.
Similar Journals
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
Pioneering insights for the future of patient care.CLINICAL AND EXPERIMENTAL RHEUMATOLOGY is a prestigious journal published by CLINICAL & EXPER RHEUMATOLOGY, dedicated to advancing the field of rheumatology and immunology. With a rich history dating back to 1983, the journal serves as a critical platform for researchers, clinicians, and professionals seeking to disseminate and discuss innovative findings in these rapidly evolving areas. Featuring an impressive Q2 ranking in both Immunology and Allergy, as well as Rheumatology, this journal is recognized for its high-quality contributions, placing it among the top tier of academic publications. Operating without an open access model, CLINICAL AND EXPERIMENTAL RHEUMATOLOGY is headquartered in Pisa, Italy, and publishes articles that undergo rigorous peer review to ensure excellence in research. This journal is an invaluable resource for those dedicated to improving patient outcomes through evidence-based practice in rheumatology, immunology, and related fields.
Current Rheumatology Reviews
Advancing knowledge in rheumatology.Current Rheumatology Reviews is an esteemed journal dedicated to publishing comprehensive reviews on advancements in the field of rheumatology. Established by Bentham Science Publishers, this journal has become a vital resource for researchers, clinicians, and students seeking to stay abreast of the latest developments and therapeutic strategies from 2006 to 2024. Located in the United Arab Emirates, it caters to a global audience, delivering insights that have been pivotal in shaping clinical practices. With an impact factor reflective of its Q3 status in Rheumatology by 2023, the journal ranks #46 out of 73 in the Scopus database, positioning it in the 37th percentile in the discipline. Although it operates without open access, its high-quality content ensures that each article undergoes rigorous peer review, making the Current Rheumatology Reviews a trusted platform for disseminating critical research findings and reviews that drive forward the understanding and treatment of rheumatic diseases.
Arthritis & Rheumatology
Exploring Breakthroughs in Arthritis and ImmunologyArthritis & Rheumatology is a leading journal dedicated to the advancement of knowledge in the fields of rheumatology, immunology, and allergy. Published by WILEY in the United Kingdom, this prestigious journal boasts an impressive impact factor and a prominent reputation, ranking in the Q1 category across multiple disciplines, including Immunology and Rheumatology. With its high ranking of 4th out of 73 in Rheumatology and notable standings in related fields, it serves as a crucial platform for researchers, healthcare professionals, and scholars to disseminate groundbreaking findings. The journal embraces an Open Access model, enhancing the accessibility of vital research to a global audience and ensuring that knowledge dissemination is maximized. Since its inception in 2014, Arthritis & Rheumatology has been at the forefront of impactful research, fostering collaboration and innovation in tackling complex challenges within these medical disciplines. Researchers looking to explore the latest advancements and engage with cutting-edge studies in these fields will find this journal to be an essential resource.
Modern Rheumatology Case Reports
Pioneering clinical narratives that inform and inspire rheumatology practice.Modern Rheumatology Case Reports, published by Oxford University Press, is an essential platform dedicated to the dissemination of unique clinical cases within the field of rheumatology. Launched in 2017, this journal provides a valuable resource for researchers, clinicians, and students interested in the nuances of rheumatological conditions and their management. With an E-ISSN of 2472-5625, the journal is accessible to a global audience, fostering knowledge exchange and collaborative research. Although currently ranked in the Q4 quartile and positioned 53rd out of 73 in the Scopus Medicine Rheumatology category, the journal is committed to enhancing its impact in the discipline by focusing on innovative case reports that inform clinical practice and contribute to the evolving understanding of rheumatic diseases. This endeavor not only supports the academic community but also aims to inspire new avenues for research and diagnostics. As such, Modern Rheumatology Case Reports is poised to become a significant reference point for those dedicated to advancing rheumatological care.
Indian Journal of Rheumatology
Elevating the discourse in rheumatology for better health outcomes.Welcome to the Indian Journal of Rheumatology, a premier scholarly platform dedicated to advancing research and clinical practice in the field of rheumatology. Published by SAGE Publications Inc., this journal has been providing open access to its valuable content since 2006, promoting the dissemination of knowledge in India and beyond. As a voice in the rheumatology community, the journal addresses a wide range of topics including epidemiology, diagnostics, treatment strategies, and patient care in rheumatic diseases. Despite being classified in the Q4 category of the 2023 Scopus rankings, with a current position of Rank #57 among 73 journals, it serves as an essential resource for researchers, healthcare professionals, and students seeking to stay updated with the latest developments. The journal is committed to fostering scholarly dialogue and facilitating access to research that influences practice and improves patient outcomes in rheumatologic care.
ARP Rheumatology
Elevating Knowledge in the Realm of RheumatologyARP Rheumatology is a pioneering open-access journal dedicated to the field of rheumatology, published by the esteemed Sociedade Portuguesa Reumatologia. Since its inception in 2022, this journal has aimed to bridge the gap between research and clinical practice, providing a platform for the dissemination of high-quality research, case studies, and reviews that advance the understanding and management of rheumatic diseases. Although currently classified in the Q4 category of rheumatology journals with a Scopus rank of 56/73, our commitment to academic excellence and engagement with our readership is unwavering. Located in Portugal, ARP Rheumatology supports a global community of researchers, professionals, and students by maintaining rigorous peer-review standards and promoting innovative scientific discourse. With accessible content and a focus on the latest advancements in the field, ARP Rheumatology is poised to make a significant impact on the future of rheumatology research and practice.
RHEUMATOLOGY INTERNATIONAL
Elevating the standards of rheumatological science.Rheumatology International, published by Springer Heidelberg, is a prestigious journal that focuses on innovative research in the field of rheumatology and immunology. Established in 1981, this peer-reviewed journal has contributed significantly to advancing our understanding of autoimmune disorders, clinical approaches, and therapeutic interventions. It holds a commendable Q2 ranking in the categories of Immunology, Immunology and Allergy, and Rheumatology as of 2023, showcasing its influence and importance within these disciplines. With a robust Scopus ranking—positioned 14 out of 73 in Medicine Rheumatology—it caters to a diverse audience of researchers, clinicians, and students committed to improving patient care and treatment modalities. Although it does not currently offer open access options, the journal remains a vital resource for insights on contemporary challenges and breakthroughs in rheumatological research, published from its base in Heidelberg, Germany.
SEMINARS IN ARTHRITIS AND RHEUMATISM
Elevating research standards in arthritis and rheumatism.SEMINARS IN ARTHRITIS AND RHEUMATISM, published by W B Saunders Co-Elsevier Inc, is a leading journal in the fields of rheumatology and pain medicine. With an impressive impact factor and recognized as a Q1 journal in both its categories, it ranks #8 in Anesthesiology and Pain Medicine and #11 in Rheumatology based on the latest Scopus data, placing it within the top echelons of academic research. Established in 1971, this esteemed publication offers a comprehensive platform for researchers and practitioners to disseminate and engage with cutting-edge studies that advance the understanding and treatment of arthritis and related conditions. With its robust editorial process and focus on high-quality, peer-reviewed articles, the journal not only contributes to scientific knowledge but also serves as an essential resource for professionals and students seeking contemporary insights into effective management strategies and emerging therapies in the rheumatologic field. Although it does not offer open access, its subscription model ensures a wide distribution among academic and clinical institutions, reinforcing its significance in the research community.
ZEITSCHRIFT FUR RHEUMATOLOGIE
Exploring cutting-edge findings in rheumatic disease treatment.ZEITSCHRIFT FUR RHEUMATOLOGIE, published by Springer Heidelberg, serves as a vital platform in the field of rheumatology, providing researchers, clinicians, and students with cutting-edge findings and discussions related to the diagnosis, treatment, and management of rheumatic diseases. Since its inception in 1974 and continuing until 2024, this journal retains its commitment to disseminating significant scientific work within this specialized domain. Although it is currently categorized in the Q4 quartile for Rheumatology and ranks 47 out of 73 in Scopus, reflecting its burgeoning presence, the journal is dedicated to evolving and gaining prominence in the academic community. By offering valuable insights and fostering scholarly discourse, ZEITSCHRIFT FUR RHEUMATOLOGIE plays a crucial role in advancing rheumatology research and enhancing patient care practices worldwide. The journal presents an opportunity for its readers to engage with contemporary studies and enrich their understanding of rheumatic ailments.
Advances in Rheumatology
To innovate, educate, and transform rheumatology.Advances in Rheumatology is a premier open-access journal published by BMC, dedicated to advancing the field of rheumatology through high-quality, peer-reviewed research. Launched in 2018, the journal has quickly established itself within the academic community, achieving a commendable Q2 ranking in the category of Rheumatology as of 2023 and ranking #34 out of 73 in the Scopus Medicine Rheumatology listings, placing it in the 54th percentile. With a focus on innovative treatments, patient care, and the latest in rheumatological research, the journal provides a platform for researchers and clinicians to disseminate their findings and foster collaborative advancements in this critical area of medicine. Recognized for its accessibility, the journal follows an open-access model, ensuring that research is freely available to a global audience. With a commitment to high standards of academic rigor, Advances in Rheumatology plays a vital role in enhancing the understanding and treatment of rheumatic diseases, making it an invaluable resource for researchers, professionals, and students alike.